
Tuesday, May 21, 2024 11:06:57 AM
Recent NKLAQ News
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 04/10/2025 08:27:25 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 04/10/2025 08:25:20 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 04/10/2025 08:23:35 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 04/10/2025 08:21:44 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 04/10/2025 08:19:35 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/09/2025 04:15:30 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/07/2025 09:09:06 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/07/2025 09:07:34 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/07/2025 09:05:58 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/07/2025 09:04:05 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/07/2025 09:02:34 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/07/2025 09:00:28 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/07/2025 08:59:01 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/07/2025 08:57:26 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/07/2025 08:55:23 PM
FEATURED Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs • CLDI • Jul 7, 2025 9:00 AM
VAYK Discloses More Insider Buying Approaching 15 Million • VAYK • Jul 2, 2025 10:37 AM